Charming Medical Limited
MCTA
$29.36
$1.866.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | 54.15% | -- | -- | -- | |
| Total Depreciation and Amortization | -32.69% | -- | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 79.71% | -- | -- | -- | |
| Change in Net Operating Assets | -23.05% | -- | -- | -- | |
| Cash from Operations | 44.14% | -- | -- | -- | |
| Capital Expenditure | -36.47% | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | -958.59% | -- | -- | -- | |
| Total Debt Issued | 435.94% | -- | -- | -- | |
| Total Debt Repaid | -1.82% | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 118.70% | -- | -- | -- | |
| Cash from Financing | 421.20% | -- | -- | -- | |
| Foreign Exchange rate Adjustments | 55.77% | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -837.84% | -- | -- | -- | |